导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 22.19% | 330/4773 |
| 近一周 | -5.00% | 5280/5465 |
| 近一月 | 0.96% | 393/5421 |
| 近一季 | 3.99% | 404/5231 |
| 近半年 | -0.98% | 1644/4920 |
| 近一年 | 21.17% | 462/4394 |
| 近两年 | 32.84% | 2174/2954 |
| 近三年 | 19.92% | 1488/2253 |
| 成立以来 | 67.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
17.40% 35/4961 |
-12.17% 4380/5312 |
- - |
- - |
| 2025 | -5.06% 3367/4813 |
-9.71% 3437/3635 |
-2.00% 3292/4076 |
7.30% 3460/4524 |
- 2290/4813 |
| 2024 | 1.06% 2030/3463 |
7.13% 258/2808 |
-1.09% 925/3014 |
4.63% 2892/3129 |
-8.85% 2885/3463 |
| 2023 | 10.08% 104/2656 |
3.17% 1249/2280 |
-6.26% 1612/2385 |
9.67% 5/2515 |
3.78% 46/2655 |
| 2022 | 15.80% 4/2207 |
21.08% 4/1919 |
9.00% 308/2016 |
4.30% 4/2113 |
-15.88% 2080/2208 |
| 2021 | 46.05% 13/1822 |
4.24% 154/1255 |
18.88% 169/1330 |
38.30% 5/1466 |
-14.78% 1633/1822 |
| 2020 | 15.42% 783/1250 |
-16.14% 990/1022 |
2.01% 977/1060 |
14.30% 279/1152 |
- - |
| 2019 | 23.26% 632/1092 |
20.95% 600/748 |
- 200/797 |
-1.76% 672/844 |
3.73% 828/912 |
| 2018 | -30.84% 480/834 |
- - |
- - |
- - |
-13.02% 503/691 |
| 2017 | 11.66% 294/714 |
- - |
- - |
- - |
- - |
| 2016 | 3.65% 80/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 富国中证煤炭指数(LOF)A VS. 长安沪深300非周期A(740101) |